Bridge Growth Partners/Finalsite: Represented Bridge Growth Partners, LLC in its acquisition of Finalsite, a leading SaaS-based learning and communications platform for U.S. and international schools.
Eurazeo/Glion Institute of Higher Education/Les Roches International School of Hotel Management: Represented Eurazeo on the financing aspects of its CHF 380 million acquisition of Glion Institute of Higher Education and Les Roches International School of Hotel Management.
Innopolis/Carnegie Mellon University, iCarnegie Global Learning LLC, Innopolis University: Represented Innopolis, an autonomous non-profit organization, and its parent company in the initial phases of the development of Innopolis University. iCarnegie Global Learning LLC and Carnegie Mellon University have signed an agreement with the Russian Republic of Tatarstan and Autonomous noncommercial organization (ANO) “Innopolis University,” for the development of Innopolis University, a new world-class center of excellence for learning, teaching, research and entrepreneurship. Willkie represented Innopolis, an autonomous non-profit organization, and its parent company in the initial phases of the project.
Insight Venture Capital, Redpoint Ventures/OpenEnglish: Advised Insight Venture Capital and Redpoint Ventures in a tender offer to buy out shares from previous investors in the online language school OpenEnglish, as part of an initial investment in the company valued at $42.9 million. Redpoint Ventures announced that the $130 million raised in early-stage funding would support OpenEnglish’s Brazilian market expansion strategy.
iParadigms/Insight/Warburg Pincus: Represented iParadigms, a California-based anti-plagiarism software company, in its $752 million sale to Insight Venture partners and GIC, Singapore's sovereign wealth fund, from majority owner Warburg Pincus.
NYU Medical School, Weizmann Institute of Science (Israel), University of Pennsylvania, the University of Colorado, Oregon Health Sciences University, the Max Planck Institute (Germany): Advised leading academic and research institutions in matters regarding (a) the negotiation of license agreements for the licensing of patented technology of the universities to pharmaceutical or biotechnology companies, (b) the negotiation of individual or multi-project sponsored research agreements between universities and industrial partners, or (c) the receipt by the universities as consideration for their licenses of various forms of equity interests in early stage companies formed to exploit the inventions made at the universities.
Warburg Pincus/ACAMS: Represented Warburg Pincus and the Association of Certified Anti-Money Laundering Specialists (ACAMS) in the $330 million sale of ACAMS to Becker Professional Education.